Acumen Pharmaceuticals (ABOS) EPS (Diluted) (2021 - 2026)

Acumen Pharmaceuticals (ABOS) EPS (Diluted) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 66,561.01 Bn 66,560.72 Bn - 0.00
2 Nanobiotix 1,919.96 Bn 1,919.90 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - 0.00
4 BeOne Medicines 470.70 Bn 465.91 Bn 1.35 Bn 0.15
5 Vertex Pharmaceuticals 122.12 Bn 114.88 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 69.94 Bn 61.18 Bn 3.31 Bn 6.75
7 Belite Bio 62.06 Bn 62.06 Bn - 0.00
8 Argenx Se 55.79 Bn 50.61 Bn 1.41 Bn 7.33
9 Alnylam Pharmaceuticals 37.52 Bn 34.51 Bn 959.66 Mn 1.49
10 Acumen Pharmaceuticals 140.66 Mn 140.66 Mn - -0.33

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.33
Dec 31, 2025 -0.41
Sep 30, 2025 -0.43
Jun 30, 2025 -0.67
Mar 31, 2025 -0.48
Dec 31, 2024 -0.61
Sep 30, 2024 -0.50
Jun 30, 2024 -0.36
Mar 31, 2024 -0.25
Dec 31, 2023 -0.30
Sep 30, 2023 -0.24
Jun 30, 2023 -0.28
Mar 31, 2023 -0.32
Dec 31, 2022 -0.35
Sep 30, 2022 -1.26
Jun 30, 2022 -0.57
Mar 31, 2022 -0.23
Dec 31, 2021 -0.42
Sep 30, 2021 -0.10
Jun 30, 2021 -127.36